Sign In
Buy R
$260.38
+2.32 (+0.90%)
At Close: Jun 03, 2026
Why Is Ryder (R) Down 15.3% Since Last Earnings Report?
12:35pm, Friday, 14'th Mar 2025
Ryder (R) reported earnings 30 days ago. What's next for the stock?
Delivra Health Brands' Dream Water(R) Brand Drives Growth with Launch of 6-Count Sleep Gummies into the Canadian Market
07:00am, Wednesday, 12'th Mar 2025
Vancouver, British Columbia--(Newsfile Corp. - March 12, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely p
Theralase(R) Releases 2024 Annual Financial Statements
07:00am, Wednesday, 12'th Mar 2025
Toronto, Ontario--(Newsfile Corp. - March 12, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to th
Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
04:05pm, Monday, 10'th Mar 2025
LOS GATOS, CA / ACCESS Newswire / March 10, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ)
Ryder Chairman & CEO Robert Sanchez to Address J.P. Morgan 2025 Industrials Conference
06:55am, Wednesday, 05'th Mar 2025
MIAMI--(BUSINESS WIRE)--Ryder System, Inc. (NYSE: R) Chairman & CEO Robert Sanchez to address J.P. Morgan 2025 Industrials Conference. Who: Ryder System, Inc. Chairman & CEO Robert Sanchez
Here's Why Investors Should Give Ryder System Stock a Miss Now
09:36am, Wednesday, 26'th Feb 2025
Weak freight market conditions and elevated operating expenses are severely hurting Ryder's prospects.
Theralase(R) Demonstrates Efficacy of Rutherrin(R) in Destruction of Non-Hodgkin's Lymphoma
04:15pm, Tuesday, 25'th Feb 2025
Rutherrin(R), when combined with a common diabetic drug and radiation, was able to effectively destroy Non-Hodgkin's Lymphoma in an animal model. Toronto, Ontario--(Newsfile Corp. - February 25, 2025)
PARSIPPANY, N.J. and TEL AVIV, Israel and PARIS, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell (E
Brisbane, Queensland, Australia--(Newsfile Corp. - February 24, 2025) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce the results of the
Ryder Leaders Reach Rock-Star Status in Food Logistics
06:55am, Thursday, 20'th Feb 2025
MIAMI--(BUSINESS WIRE)-- #RyderEverbetter--Ryder sweeps the 2025 Rock Stars of the Supply Chain awards by Food Logistics with three leaders from its consumer-packaged goods (CPG) business.
One-year follow-up data demonstrates sustained improvements across venous specific quality-of-life (QoL) indicators. PMA application for the VenoValve submitted in November 2024, with an FDA decision
Bob Gold & Associates Named Agency of Record for the Largest Broadband Show in the Americas, SCTE TechExpo25
12:00pm, Tuesday, 18'th Feb 2025
LOS ANGELES--(BUSINESS WIRE)-- #BobGoldPR--SCTE TechExpo25, the largest broadband event of its kind, names Bob Gold & Associates as its Agency of Record to drive industry engagement.
CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World's Top Innovators
07:15am, Tuesday, 18'th Feb 2025
CureVac among global top 100 most fast-paced innovators for third consecutive year in acknowledgment of its innovative strength and extensive intellectual property portfolio The company holds one of t
Fortune Names Ryder Among World's Most Admired Companies in 2025
06:55am, Tuesday, 18'th Feb 2025
MIAMI--(BUSINESS WIRE)--Ryder System, Inc. (NYSE: R) announces its recognition by Fortune magazine as one of the World's Most Admired Companies for 2025. This is the 13th consecutive year Ryder has be
Ryder Q4 Earnings Surpass Estimates, Improves Year Over Year
10:15am, Friday, 14'th Feb 2025
R's fourth-quarter 2024 results reflect higher earnings across all business segments.
